99 related articles for article (PubMed ID: 18926291)
1. Recent advances in the genetic analysis of PTEN and PI3K innate immune properties.
Günzl P; Schabbauer G
Immunobiology; 2008; 213(9-10):759-65. PubMed ID: 18926291
[TBL] [Abstract][Full Text] [Related]
2. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.
Sahin E; Haubenwallner S; Kuttke M; Kollmann I; Halfmann A; Dohnal AM; Chen L; Cheng P; Hoesel B; Einwallner E; Brunner J; Kral JB; Schrottmaier WC; Thell K; Saferding V; Blüml S; Schabbauer G
J Immunol; 2014 Aug; 193(4):1717-27. PubMed ID: 25015834
[TBL] [Abstract][Full Text] [Related]
3. Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
Hafsi S; Pezzino FM; Candido S; Ligresti G; Spandidos DA; Soua Z; McCubrey JA; Travali S; Libra M
Int J Oncol; 2012 Mar; 40(3):639-44. PubMed ID: 22200790
[TBL] [Abstract][Full Text] [Related]
4. The Role of PTEN in Innate and Adaptive Immunity.
Taylor H; Laurence ADJ; Uhlig HH
Cold Spring Harb Perspect Med; 2019 Dec; 9(12):. PubMed ID: 31501268
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
[TBL] [Abstract][Full Text] [Related]
6. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.
Barata JT
Adv Enzyme Regul; 2011; 51(1):37-49. PubMed ID: 21035501
[TBL] [Abstract][Full Text] [Related]
7. Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation.
Calderón L; Schindler K; Malin SG; Schebesta A; Sun Q; Schwickert T; Alberti C; Fischer M; Jaritz M; Tagoh H; Ebert A; Minnich M; Liston A; Cochella L; Busslinger M
Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34301800
[TBL] [Abstract][Full Text] [Related]
8. The PTEN-PI3K pathway: of feedbacks and cross-talks.
Carracedo A; Pandolfi PP
Oncogene; 2008 Sep; 27(41):5527-41. PubMed ID: 18794886
[TBL] [Abstract][Full Text] [Related]
9. Regulation of T-cell responses by PTEN.
Buckler JL; Liu X; Turka LA
Immunol Rev; 2008 Aug; 224():239-48. PubMed ID: 18759931
[TBL] [Abstract][Full Text] [Related]
10. Still waiting for the toll?
Cooper EL; Kvell K; Engelmann P; Nemeth P
Immunol Lett; 2006 Apr; 104(1-2):18-28. PubMed ID: 16368151
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors and innate immunity.
Kumar H; Kawai T; Akira S
Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
[TBL] [Abstract][Full Text] [Related]
12. The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development.
Benhamou D; Labi V; Getahun A; Benchetrit E; Dowery R; Rajewsky K; Cambier JC; Melamed D
Front Immunol; 2018; 9():2715. PubMed ID: 30524445
[TBL] [Abstract][Full Text] [Related]
13. ESAT-6 induced COX-2 expression involves coordinated interplay between PI3K and MAPK signaling.
A SK; Bansal K; Holla S; Verma-Kumar S; Sharma P; Balaji KN
Mol Immunol; 2012 Jan; 49(4):655-63. PubMed ID: 22154837
[TBL] [Abstract][Full Text] [Related]
14. Autophagy in regulation of Toll-like receptor signaling.
Into T; Inomata M; Takayama E; Takigawa T
Cell Signal; 2012 Jun; 24(6):1150-62. PubMed ID: 22333395
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation.
Günzl P; Bauer K; Hainzl E; Matt U; Dillinger B; Mahr B; Knapp S; Binder BR; Schabbauer G
J Leukoc Biol; 2010 Dec; 88(6):1259-69. PubMed ID: 20884649
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
McCubrey JA; Steelman LS; Kempf CR; Chappell WH; Abrams SL; Stivala F; Malaponte G; Nicoletti F; Libra M; Bäsecke J; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Cocco L; Martelli AM
J Cell Physiol; 2011 Nov; 226(11):2762-81. PubMed ID: 21302297
[TBL] [Abstract][Full Text] [Related]
18. New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.
Ruse M; Knaus UG
Immunol Res; 2006; 34(1):33-48. PubMed ID: 16720897
[TBL] [Abstract][Full Text] [Related]
19. The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer.
Chen K; Iribarren P; Gong W; Wang JM
Cell Mol Immunol; 2005 Aug; 2(4):241-52. PubMed ID: 16274621
[TBL] [Abstract][Full Text] [Related]
20. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.
Peltier DC; Simms A; Farmer JR; Miller DJ
J Immunol; 2010 Jun; 184(12):7010-21. PubMed ID: 20483728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
